Article Versions Notes

Chelabi S, Mignard X, Leroy K, Monnet I, Brosseau S, Theou-Anton N, Massiani M-A, Friard S, Duchemann B, Fabre E, et al. EGFR Exon 20 Insertion in Metastatic Non-Small-Cell Lung Cancer: Survival and Clinical Efficacy of EGFR Tyrosine-Kinase Inhibitor and Chemotherapy. Cancers. 2021; 13(20):5132. https://doi.org/10.3390/cancers13205132

Chelabi, Samy, Xavier Mignard, Karen Leroy, Isabelle Monnet, Solenn Brosseau, Nathalie Theou-Anton, Marie-Ange Massiani, Sylvie Friard, Boris Duchemann, Elizabeth Fabre, and et al. 2021. "EGFR Exon 20 Insertion in Metastatic Non-Small-Cell Lung Cancer: Survival and Clinical Efficacy of EGFR Tyrosine-Kinase Inhibitor and Chemotherapy" Cancers 13, no. 20: 5132. https://doi.org/10.3390/cancers13205132

Chelabi, S., Mignard, X., Leroy, K., Monnet, I., Brosseau, S., Theou-Anton, N., Massiani, M.-A., Friard, S., Duchemann, B., Fabre, E., Giroux-Leprieur, E., Cadranel, J., & Wislez, M. (2021). EGFR Exon 20 Insertion in Metastatic Non-Small-Cell Lung Cancer: Survival and Clinical Efficacy of EGFR Tyrosine-Kinase Inhibitor and Chemotherapy. Cancers, 13(20), 5132. https://doi.org/10.3390/cancers13205132